Pharmacy Model Agree CDTM Hospital
Pharmacy Model Agree CDTM Hospital
Pharmacy Model Agree CDTM Hospital
d.
e.
f.
g.
h.
i.
ii.
iii.
d.
e.
f.
g.
h.
PROCEDURE:
Page 5
A. Registration Requirements
In order to issue, modify or discontinue a written prescription, oral prescription or
medication order in accordance with requirements for collaborative drug therapy
management for Schedule II through VI drugs, pharmacists must register with the
Massachusetts Department of Public Health, Division of Food and Drugs, and the
United States Drug Enforcement Administration.
In order to register, pharmacists must meet all licensure requirements set by their
respective boards of registration and must also have completed the requisite
continuing education requirement of 5 hours of pharmaco-therapeutics in addition to
their annual 15 hour CME requirement.
The registration requirements are set out in detail in 105 Code of Massachusetts
Regulations
700.003 (C), 700.003(I), and 700.004 and in 21 Code of Federal Regulations 1300.
These regulations are available through your hospitals Office of General Counsel.
B. Supervisory Requirements
Each pharmacist who prescribes controlled substances must do so pursuant to a
written CDTM agreement. The pharmacist must meet all applicable requirements of
the BORP. The supervising physician or physician designee for a pharmacist must
hold an unrestricted, full license from the BORM; must have completed an ACGMEaccredited or accredited Canadian post-graduate medical training in a specialty area
appropriately related to the pharmacists area of practice; and be board-certified or
board eligible, in a specialty area appropriately related to the pharmacists area of
practice, or have hospital admitting privileges in a specialty area appropriately
related to the pharmacists area of practice. The supervising physician or physician
designee and the pharmacist will work together in accordance with the prescribing
guidelines described below.
Only pharmacists with a full (not temporary or
provisional) Massachusetts license, a current Federal DEA registration, and a current
Massachusetts Controlled Substances Registration may prescribe.
C. Prescribing Guidelines
Written guidelines for prescribing must exist in the practice setting representing the
relationship between the supervising physician or physician designee and the
pharmacist. CDTM agreements and specific CDTM protocols for pharmacists must be
reviewed annually and dated and signed by the physician and the pharmacist at the
time of each such review.
The content of a CDTM agreement/protocol for a pharmacist must include but is not
limited to:
a. The identification of the supervising physician for that setting;
b. A description of the nature and scope of the pharmacist practice;
c. The types and classes of and limitations on medications to be prescribed by
pharmacists;
d. The quantity of any medication to be prescribed including initial dosage limits
and refills if applicable;
e. The frequency for reviewing initial prescriptions and changes in medications;
Page 6
f.
Page 7